Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Steuber

Showing results (81-90 of 209) with videos related to

Pageof 21
Sort By:
International Journal of Molecular Sciences|March 6, 2013
A Cancer-Indicative microRNA Pattern in Normal Prostate TissueOlaf J C Hellwinkel, Christina Sellier, Yu-Mi Jessica Sylvester, et al.
BJU International|January 20, 2011
Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decadeLars Budäus, Jan Spethmann, Hendrik Isbarn, et al.
BJU International|February 5, 2010
Prognostic significance of a positive surgical margin in pathologically organ-confined prostate cancerSascha A Ahyai, Mario Zacharias, Hendrik Isbarn, et al.
BJU International|February 26, 2015
Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteriaPhilipp Mandel, Thomas Steuber, Sascha Ahyai, et al.
BJU International|April 24, 2012
Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patientsLars Budäus, Hendrik Isbarn, Pierre Tennstedt, et al.
Urologic Oncology|October 24, 2020
Oncological outcomes of pathologically organ-confined, lymph node-positive prostate cancer after radical prostatectomyLara Franziska Stolzenbach, Sophie Knipper, Philipp Mandel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 13, 2025
Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapyMike Wenzel, Benedikt Hoeh, Carolin Siech, et al.
BJU International|August 14, 2012
Accuracy of HistoScanning™ for the prediction of a negative surgical margin in patients undergoing radical prostatectomyGeorg Salomon, Jan Spethmann, Ann Beckmann, et al.
Urologic Oncology|July 11, 2026
Impact of number of bone metastases on cancer control outcomes in mHSPC, independent of the axial-skeleton CHAARTED definitionMike Wenzel, Lena Theissen, Carolin Siech, et al.
BJU International|March 31, 2019
A comparative study of robot-assisted and open radical prostatectomy in 10 790 men treated by highly trained surgeons for both proceduresAlexander Haese, Sophie Knipper, Hendrik Isbarn, et al.
Pageof 21

Showing results (81-90 of 209) with videos related to

Sort By:
Pageof 21
International Journal of Molecular Sciences|March 6, 2013
A Cancer-Indicative microRNA Pattern in Normal Prostate TissueOlaf J C Hellwinkel, Christina Sellier, Yu-Mi Jessica Sylvester, et al.
BJU International|January 20, 2011
Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decadeLars Budäus, Jan Spethmann, Hendrik Isbarn, et al.
BJU International|February 5, 2010
Prognostic significance of a positive surgical margin in pathologically organ-confined prostate cancerSascha A Ahyai, Mario Zacharias, Hendrik Isbarn, et al.
BJU International|February 26, 2015
Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteriaPhilipp Mandel, Thomas Steuber, Sascha Ahyai, et al.
BJU International|April 24, 2012
Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patientsLars Budäus, Hendrik Isbarn, Pierre Tennstedt, et al.
Urologic Oncology|October 24, 2020
Oncological outcomes of pathologically organ-confined, lymph node-positive prostate cancer after radical prostatectomyLara Franziska Stolzenbach, Sophie Knipper, Philipp Mandel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 13, 2025
Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapyMike Wenzel, Benedikt Hoeh, Carolin Siech, et al.
BJU International|August 14, 2012
Accuracy of HistoScanning™ for the prediction of a negative surgical margin in patients undergoing radical prostatectomyGeorg Salomon, Jan Spethmann, Ann Beckmann, et al.
Urologic Oncology|July 11, 2026
Impact of number of bone metastases on cancer control outcomes in mHSPC, independent of the axial-skeleton CHAARTED definitionMike Wenzel, Lena Theissen, Carolin Siech, et al.
BJU International|March 31, 2019
A comparative study of robot-assisted and open radical prostatectomy in 10 790 men treated by highly trained surgeons for both proceduresAlexander Haese, Sophie Knipper, Hendrik Isbarn, et al.
Pageof 21